Abstract Background: Tumor biology is driven not only by genetic and epigenetic alterations but also by disruptions in circadian timing, immune rhythms, and tissue-level dynamics. Cancer often exploits temporal disarray to evade apoptosis and immune detection, yet time-based vulnerabilities remain underutilized in therapy. Objective: This paper introduces a relativistic, cross-disciplinary framework in which cancer is conceptualized as a temporally misaligned system. The aim is to translate theoretical constructs into experimentally testable strategies for chrono-immunotherapy. Methods: Three interlocking hypotheses are proposed: (i) Localized Emotion Generation (LEG), the failure of tumors to produce coherent immune-signaling cues; (ii) Circadian Illusion Engineering (CIE), the induction of localized “death zones” through phase inversion of rhythmic signals; and (iii) the Hurricane Eye Model (HEM), which describes the hypoxic tumor core as a rhythm-free sanctuary requiring targeted disruption. These are unified under a Relativistic Compartmental Model (RCM) that treats cancer as a compartment existing in accelerated biological time. Results: Evidence from chronobiology, immunology, and pharmacology supports this approach. Clock gene disruption (PER2, BMAL1) accelerates tumorigenesis; selective serotonin reuptake inhibitors (SSRIs) induce apoptosis and recalibrate T-cell energetics; interferon-β pacing improves viral immunogenicity and tumor clearance. Each hypothesis is aligned with measurable biomarkers (PER2::Luc oscillations, cytokine gradients, hypoxic markers) and tractable experimental systems (organoids, hypoxic spheroids, murine models). Conclusion: This relativistic-chronobiological framework proposes testable strategies that reconceptualize cancer not as an invader to be eliminated but as a temporal anomaly to be re-synchronized. In this vision, therapeutic interventions may act as “micro-time machines,” locally restoring coherence by shifting cellular and tissue rhythms back into systemic alignment. This framework likewise integrates biomedical evidence with broader conceptual insights, offering a vision of oncology grounded in coherence, transformation, and systemic realignment.
Theodor-Nicolae Carp (Thu,) studied this question.